DE60331586D1 - Festphase fluorierung von uracil - Google Patents

Festphase fluorierung von uracil

Info

Publication number
DE60331586D1
DE60331586D1 DE60331586T DE60331586T DE60331586D1 DE 60331586 D1 DE60331586 D1 DE 60331586D1 DE 60331586 T DE60331586 T DE 60331586T DE 60331586 T DE60331586 T DE 60331586T DE 60331586 D1 DE60331586 D1 DE 60331586D1
Authority
DE
Germany
Prior art keywords
formula
tracer
fluoration
uracil
solid phase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60331586T
Other languages
English (en)
Inventor
Frank Brady
Sajinder Kaur Luthra
Edward George Robins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hammersmith Imanet Ltd
Original Assignee
Hammersmith Imanet Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hammersmith Imanet Ltd filed Critical Hammersmith Imanet Ltd
Application granted granted Critical
Publication of DE60331586D1 publication Critical patent/DE60331586D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0459Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0491Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05Isotopically modified compounds, e.g. labelled
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/11Compounds covalently bound to a solid support
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60331586T 2002-12-20 2003-12-19 Festphase fluorierung von uracil Expired - Lifetime DE60331586D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0229683.8A GB0229683D0 (en) 2002-12-20 2002-12-20 Preparation of radiopharmaceuticals
PCT/GB2003/005577 WO2004056400A1 (en) 2002-12-20 2003-12-19 Solid-phase fluorination of uracil and cytosine

Publications (1)

Publication Number Publication Date
DE60331586D1 true DE60331586D1 (de) 2010-04-15

Family

ID=9950058

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60331586T Expired - Lifetime DE60331586D1 (de) 2002-12-20 2003-12-19 Festphase fluorierung von uracil

Country Status (9)

Country Link
US (1) US7504208B2 (de)
EP (1) EP1572249B1 (de)
JP (1) JP2006510707A (de)
AT (1) ATE459377T1 (de)
AU (1) AU2003290297A1 (de)
DE (1) DE60331586D1 (de)
ES (1) ES2341102T3 (de)
GB (1) GB0229683D0 (de)
WO (1) WO2004056400A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0115927D0 (en) * 2001-06-29 2001-08-22 Nycomed Amersham Plc Solid-phase nucleophilic fluorination
US7344702B2 (en) 2004-02-13 2008-03-18 Bristol-Myers Squibb Pharma Company Contrast agents for myocardial perfusion imaging
GB0407952D0 (en) * 2004-04-08 2004-05-12 Amersham Plc Fluoridation method
US7485283B2 (en) 2004-04-28 2009-02-03 Lantheus Medical Imaging Contrast agents for myocardial perfusion imaging
US7824659B2 (en) * 2005-08-10 2010-11-02 Lantheus Medical Imaging, Inc. Methods of making radiolabeled tracers and precursors thereof
GB0524851D0 (en) * 2005-12-06 2006-01-11 Ge Healthcare Ltd Radiolabelling method using polymers
WO2009073273A2 (en) * 2007-10-03 2009-06-11 Ge Healthcare Limited Perfluoro-aryliodonium salts in nucleophilic aromatic 18f-fluorination
CA2967254C (en) 2008-02-29 2019-03-26 Lantheus Medical Imaging, Inc. Contrast agents for applications including imaging cancer
US9302990B2 (en) 2008-10-21 2016-04-05 Nutech Ventures Fluorination of aromatic ring systems
AU2015264872B2 (en) * 2008-10-21 2018-02-22 Board Of Regents Of The University Of Nebraska Fluorination of aromatic ring systems
EP2537826B1 (de) 2008-10-21 2017-03-08 Nutech Ventures, Inc. Fluorierung aromatischer Ringsysteme
DK2419096T3 (da) 2009-04-15 2020-02-03 Lantheus Medical Imaging Inc Stabilisering af radiofarmaceutiske sammensætninger under anvendelse af ascorbinsyre
US8377704B2 (en) * 2009-10-20 2013-02-19 Nutech Ventures Detection and quantification of anions
US8546578B2 (en) * 2010-02-04 2013-10-01 Nutech Ventures Iodonium Cyclophanes for SECURE arene functionalization
CN113058046A (zh) 2010-02-08 2021-07-02 兰休斯医疗成像公司 用于合成显像剂和其中间体的方法和装置
AU2013203000B9 (en) 2012-08-10 2017-02-02 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
CN105237483B (zh) * 2015-11-10 2018-04-20 东华大学 一种对称型嘧啶基碘鎓盐及其制备方法
USD813317S1 (en) 2017-03-30 2018-03-20 Chrome Cherry Design Studio (Pty) Ltd Tape forming a toy building block base

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3808097A (en) * 1972-11-28 1974-04-30 Energy Commission Production of fluorine-18 labeled 5-fluorouracil
US5312592A (en) * 1990-06-13 1994-05-17 Scanditronix Ab Disposable kit for preparation
BE1010280A3 (fr) * 1996-05-02 1998-05-05 Coincidence S A Procede et dispositif de synthese de 2-[18f] fluoro-2-deoxy-d-glucose.
DE19951715C1 (de) 1999-10-27 2001-03-22 Rossendorf Forschzent 18F-Radiotracer und deren Verwendung zum Monitoring der Expression der Cytosin-Deaminase nach Gentransfer sowie Verfahren zur Herstellung der 18F-Radiotracer
GB0115927D0 (en) 2001-06-29 2001-08-22 Nycomed Amersham Plc Solid-phase nucleophilic fluorination

Also Published As

Publication number Publication date
EP1572249A1 (de) 2005-09-14
WO2004056400A1 (en) 2004-07-08
ATE459377T1 (de) 2010-03-15
AU2003290297A1 (en) 2004-07-14
GB0229683D0 (en) 2003-01-29
US20060120958A1 (en) 2006-06-08
ES2341102T3 (es) 2010-06-15
US7504208B2 (en) 2009-03-17
JP2006510707A (ja) 2006-03-30
EP1572249B1 (de) 2010-03-03

Similar Documents

Publication Publication Date Title
ATE459377T1 (de) Festphase fluorierung von uracil
MXPA04002067A (es) Nuevas dihidropteridinonas, procedimientos para su preparacion y su uso como medicamento.
BRPI0406926A (pt) Inibidores de polimerase viral
HUP9802859A2 (hu) Acil-amino-szalicilsav-amid-származékok és alkalmazásuk peszticidként
NO20060847L (no) Substituert 2-aminotetralin til behandling av depresjon
ATE292634T1 (de) Inhibitoren der alpha-l beta-2 vermittelten zelladhäsion
ATE338461T1 (de) Pyrazolpyrimidinfungizide
BRPI0506927A (pt) compostos orgánicos
BRPI0510335A (pt) composto heterocìclico
SE0000933D0 (sv) Method of producing 6-substituted (S)-nicotine derivatives and intermediate compounds
BRPI0415203A (pt) pentanóis reestruturados, um processo para sua produção e seu uso como agentes antiinflamatórios
EA200300804A1 (ru) Усовершенствованный способ получения карбапенема
DE60229054D1 (de) Synthese von zyklopentadien derivaten
TW200719889A (en) Amino acid derivatives
BR0211903A (pt) Isoxazolopiridinonas
BR0113259A (pt) Processo para a preparação de um composto, composto e processo para a preparação de compostos
EA200700179A1 (ru) Производные пиррола, их получение и их применение в терапии
ATE373636T1 (de) Amidderivate als inhibitoren der enzymatischen aktivität von renin
BRPI0518998A2 (pt) âmega-feniloctanamidas
BRPI0409095A (pt) processos de sìntese do ácido (2s)-indolina-2-carboxìlico, e aplicação para a sìntese do perindopril
GB2441840A (en) Process for the synthesis of arylfluorenes and analogues thereof
CO5611175A2 (es) 1,2-dihidropirazol-3-onas como mediadores de citosina
TR200401488T4 (tr) CNS bozukluklarının tedavisinde faydalı indol türevleri
BR0317719A (pt) Derivados de fosforamida
NO20030500D0 (no) Dihydroporfyrinderivater og deres anvendelse

Legal Events

Date Code Title Description
8364 No opposition during term of opposition